In addition, the CTRC’s breast cancer team, led by Virginia Kaklamani, M.D., is well known for developing genomic tests that allow doctors to predict which treatment will best benefit individual breast cancer patients. CTRC breast cancer researchers also are using drugs to target breast cancer stem cells, believed by researchers to be the first step in preventing breast cancer.
Partnering with a powerhouse
Celebrating its 75th anniversary year in 2016, MD Anderson is a global leader in cancer care, research, prevention and education. It was ranked the No. 1 cancer hospital in 2016 by U.S. News & World Report’s annual “Best Hospitals” rankings and the leading cancer hospital for nine of the past 10 years.
MD Anderson is home to the largest cancer clinical trials program in the nation. Last year, more than 9,400 patients were enrolled in trials exploring innovative treatments.Back to HCB News